Medicine and HealthSignal Transduction and Targeted Therapy
Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination
X. Chi, Y. Guo, et al.
Exciting research reveals that the adenovirus-vectored COVID-19 vaccine (Ad5-nCoV) induces broadly neutralizing antibodies against Omicron and other SARS-CoV-2 variants. The study introduces ZWD12, a monoclonal antibody with remarkable potency against these variants, paving the way for new therapeutic mAb drugs and innovative broad-spectrum vaccines. This groundbreaking work was conducted by a talented group of researchers.
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Medicine and Health
A Gamma-adapted subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from infection
L. M. Coria, J. M. Rodriguez, et al.
Medicine and Health
An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation
S. Park, J. Choi, et al.
Medicine and Health
Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
T. Li, X. Han, et al.
Medicine and Health
SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants
J. Wang, K. Li, et al.
